Aldeyra Therapeutics Inc


Top Analyst Boosts Price Target for Aldeyra Therapeutics Inc (ALDX); Here’s Why

Ritu Baral sees 35% upside for Aldeyra on back of positive Phase 2a dry eye study.

Tuesday’s Biotech Insights: Aldeyra Therapeutics Inc (ALDX) and SAGE Therapeutics Inc (SAGE), Aethlon Medical, Inc. (AEMD)

A glimpse into three biotech movers: ALDX, SAGE, AEMD.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts